Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system

JAMA Psychiatry

Volumn 75, Issue 4, 2018, Pages 405-407

  Green, Traci C ^a,b,c   Clarke, Jennifer ^a,d   Brinkley Rubinstein, Lauren ^e   Marshall, Brandon D L ^b   Alexander Scott, Nicole ^f   Boss, Rebecca ^g   Rich, Josiah D ^a,b,h  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d RHODE ISLAND DEPARTMENT OF CORRECTIONS   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f RHODE ISLAND DEPARTMENT OF HEALTH   (United States)

^g and Hospitals   (United States)

^h MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DRUGS USED IN THE TREATMENT OF ADDICTION; FENTANYL; METHADONE; NALOXONE; NALTREXONE;

ADDICTION; ADULT; ATTRIBUTABLE RISK; COHORT ANALYSIS; DEATH; DRUG DEPENDENCE TREATMENT; DRUG FATALITY; DRUG OVERDOSE; FEMALE; HUMAN; INCARCERATION; LETTER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRELIMINARY DATA; PRISON; PRISONER; RETROSPECTIVE STUDY; RHODE ISLAND; ADOLESCENT; CAUSE OF DEATH; HEALTH CARE PLANNING; HOSPITAL DISCHARGE; MORTALITY; ODDS RATIO; OPIATE ADDICTION; STATISTICS AND NUMERICAL DATA; TRANSITIONAL CARE; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; BUPRENORPHINE; CAUSE OF DEATH; DRUG OVERDOSE; FEMALE; FENTANYL; HEALTH PLAN IMPLEMENTATION; HUMANS; MALE; METHADONE; MIDDLE AGED; NALTREXONE; ODDS RATIO; OPIOID-RELATED DISORDERS; PATIENT DISCHARGE; PRISONERS; PRISONS; RETROSPECTIVE STUDIES; RHODE ISLAND; TRANSITIONAL CARE; YOUNG ADULT;

EID: 85045012995     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2017.4614     Document Type: Letter

References (6)

1. O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700-10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(43):1197-1202.
2. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009; 105(1-2):83-88.
3. Merrall EL, Kariminia A, Binswanger IA, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010; 105(9):1545-1554.
4. Marsden J, Stillwell G, Jones H, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? a national prospective observational study in England. Addiction. 2017; 112(8):1408-1418.
5. Carroll JJ, Marshall BDL, Rich JD, Green TC. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study. Int J Drug Policy. 2017; 46:136-145.
6. Marshall BDL, Krieger MS, Yedinak JL, et al. Epidemiology of fentanyl-involved drug overdose deaths: a geospatial retrospective study in Rhode Island, USA. Int J Drug Policy. 2017; 46:130-135.